Reasons for discontinuing bevacizumab included bevacizumab-related toxicities (5 subjects), progressive disease (3 subjects), subject withdrawal (3 subjects), OLT evaluation and/or treatment (3 subjects), progressive thrombocytopenia (2 subjects), acute liver dysfunction after TACE (1 subject), or a combination of factors listed above (2 subjects).
"Are the PIs going to be subjected to progressive discipline if they do not adhere to the agreement?
The optimal subset of zones that best discriminated stable MCI subjects from progressive MCI subjects was then chosen according to a procedure that we describe in the second paragraph.
Notably, these progressive CN subjects included both A β positive and A β negative subjects (six CSF and PET A β negative, seven CSF and PET A β positive, and three CSF negative but PET A β positive, Fig. 4).
Progressives are subject to their own illusions -- distinctly different illusions.
Moreover, our results show that stable MCI subjects with an NTI negative score had a high education level, even slightly higher than that of the progressive MCI subjects who converted to Alzheimer's disease later than 12 months after baseline.
This notion is confirmed by the post hoc analyses, which revealed no differences between progressive MCI subjects and Alzheimer's disease patients in terms of NTI, but a significant difference in terms of MMSE.
A Newman Keuls post hoc test led to three homogeneous groups: {NTIHC} > {NTIsMCI} >{NTIpMCI∼NTIAlzheimer's disease} (Fig. 3A), which indicates that progressive MCI subjects and Alzheimer's disease patients cannot be distinguished in terms of NTI.
The second group included progressive MCI subjects who converted to Alzheimer's disease at 6 or 12 months after baseline, the third group included the progressive MCI subjects who converted to Alzheimer's disease at 18 or 24 months, and the fourth group included the stable MCI with an NTI negative score (an anatomical pattern similar to that of Alzheimer's disease patients) (Fig. 4).
We also obtained further consistent results by testing the effect of education level on the timeline of conversion to Alzheimer's disease: progressive MCI subjects who converted to Alzheimer's disease earlier than 12 months after baseline had a significantly lower level of education than those who converted later than 12 months after baseline.
